1 hr 4 min
Grant McFadden - A Pox on Your Cancer Science to Business Network (S2BN) Podcast
-
- Science
In this inaugural Science to Business Network (S2BN) podcast, Dr. Grant McFadden shares his scientific journey as well as his experience and lessons learned as an entrepreneur having formed two companies during his career. His latest company, Oncomyx, seeks to deploy an obscure poxvirus of rabbits to save human lives by using this virus to treat cancer. Grant also discusses the implications of the 40th anniversary of the eradication of smallpox (which was announced by the WHO on May 8, 1980) and also shares his perspective on the impact of COVID19 and the work he’s doing to create a SARS-CoV2 vaccine.
Grant McFadden, PhD, is a world-renowned poxvirus researcher, Professor at Arizona State University, Director of the Biodesign Center for Immunotherapy, co-Editor-in-Chief of the journal PLoS Pathogens and past President of the American Society for Virology. Having started his career in Canada, his lab pioneered the field of viral immune subversion and is credited with the discovery of a wide spectrum of virus-derived inhibitors of the immune system.
In this inaugural Science to Business Network (S2BN) podcast, Dr. Grant McFadden shares his scientific journey as well as his experience and lessons learned as an entrepreneur having formed two companies during his career. His latest company, Oncomyx, seeks to deploy an obscure poxvirus of rabbits to save human lives by using this virus to treat cancer. Grant also discusses the implications of the 40th anniversary of the eradication of smallpox (which was announced by the WHO on May 8, 1980) and also shares his perspective on the impact of COVID19 and the work he’s doing to create a SARS-CoV2 vaccine.
Grant McFadden, PhD, is a world-renowned poxvirus researcher, Professor at Arizona State University, Director of the Biodesign Center for Immunotherapy, co-Editor-in-Chief of the journal PLoS Pathogens and past President of the American Society for Virology. Having started his career in Canada, his lab pioneered the field of viral immune subversion and is credited with the discovery of a wide spectrum of virus-derived inhibitors of the immune system.
1 hr 4 min